16 Nov 2007 12:28
Immupharma PLC16 November 2007 For Immediate Release 16 November 2007 ImmuPharma PLC Appointment of NOMAD and corporate broker ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, is pleased to announce the appointment of Panmure Gordon & Co as its NOMAD and corporate broker with immediate effect. For further information, please contact: ImmuPharma PLC: 020 7152 4080Richard Warr, ChairmanDimitri Dimitriou, Chief Executive Officer Panmure Gordon & Co: 020 7459 3600Andrew Burnett This information is provided by RNS The company news service from the London Stock Exchange
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Appointment of Nomad
Related Shares
Back to RNS
Immupharma (IMM)
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.